Quantitative evaluation of altered hepatocellular foci (AHF), followed by stereological analysis was performed on standard hematoxylin and eosin-stained liver sections from control Fischer 344 (F344) rats of both sexes from seven 2-yr carcinogenicity studies conducted by the National Toxicology Program (NTP). Liver samples were collected at 6, 9, 12, 15, 18, and/or 24 months on study. Although AHF had a broad spectrum of morphological features, they could be classified into the following 5 types using previously published criteria: basophilic, eosinophilic, clear, vacuolated, and mixed cell foci. Approximately 50% of the animals had foci at 6 months, and the incidence reached nearly 100% at 15 months in both sexes. The number, size and volume fraction of AHF increased with age in both sexes; these changes were most evident for basophilic and clear cell foci. The number of basophilic foci was significantly greater in females than in males while clear cell foci were more numerous in males. This sex difference was observed at each time point. Mean number of all types of AHF in males and females at 24 months was 547 and 460 per cubic centimeter of liver, respectively. Despite the high incidence of AHF in control rats, the incidence of hepatocellular neoplasms is low. The implication is that most foci do not progress to neoplasia in control F344 rats used in 2-yr studies.
BannaschP (1976). Cytology and cytogenesis of neoplastic (hyperplastic) hepatic nodules. Cancer Res.36: 2555–2562.
2.
BannaschPMayerDHackerHJ (1980). Hepatocellular glycogenesis and hepatocarcinogenesis. Biochim. Biophys. Acta605: 217–245.
3.
BannaschPBennerUHackerHJ (1984). Tigroid cell foci and their possible relation to hepatic tumors. In: Pharmacological, Morphological and Physiological Aspects of Liver Aging, Van BezooijenCFA (ed). Eurage, Rijswijk, pp. 195–205.
4.
BannaschPBennerUEnzmannHHackerHJ (1985). Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1. Carcinogenesis6: 1641–1648.
5.
BannaschPMooreMAHackerHJKlimekFMayerDEnzmannHZerbanH (1985). Potential significance of phenotypic instability in focal and nodular liver lesions induced by hepatocarcinogens. In: Hepatology, BrunnerHThalerH (eds). Raven Press, New York, pp. 191–209.
6.
BannaschPZerbanHHackerHJ (1985). Foci of altered hepatocytes, rat. In: Monographs on Pathology of Laboratory Animals, Digestive System, JonesTCMohrUHuntRD (eds). Springer-Verlag, Berlin, Heidelberg, New York, Tokyo, pp. 10–30.
7.
BannaschPGriesemerRAAndersFBeckerRCabralJRPortaGDFeronVJHenschlerDItoNKroesRMageePNMontesanoRNapalkovNPNesnowSRaoGNWilbournJ (1986). Early preneoplastic lesions. In: Long-term and Short-term Assays for Carcinogens: A Critical Appraisal (IARC Scientific Publications No. 83), MontesanoRBartschHVainaioHWilbournJYamasakiH (eds). International Agency for Research on Cancer/International Programme on Chemical Safety Commission of the European Communities, Lyon, pp. 85–101.
8.
BannaschP (1986). Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis7: 689–695.
9.
BuchmannAKuhlmannWSchwarzMKunzWWolfCRMollEFriedbergTOeschF (1985). Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutatione transferase B and C and microsomal epoixide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis6: 513–521.
10.
CampbellHAPitotHCPotterVRLaishesBA (1982). Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res.42: 465–472.
11.
CampbellHAXuYDHaniganMHPitotHC (1986). Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver. J. Natl. Cancer Inst.76: 751–767.
12.
DaoustRMolnarF (1964). Cellular populations and mitotic activity in rat liver parenchyma during azo dye carcinogenesis. Cancer Res.24: 1898–1909.
13.
DaoustRCalamaiR (1971). Hyperbasophilic foci as sites of neoplastic transformation in hepatic parenchyma. Cancer Res.31: 1290–1296.
14.
EmmelotPSchererE (1980). The first relevant cell stage in rat liver carcinogenesis. A quantitative approach. Biochim. Biophys. Acta605: 247–304.
15.
EnzmannHBannaschP (1987). Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis8: 1607–1612.
16.
FarberE (1980). The sequential analysis of liver cancer induction. Biochim. Biophys. Acta605: 149–166.
17.
FordJOPereiraMA (1980). Short-term in vivo initiation/promotion bioassay for hepatocarcinogens. J. Environ. Pathol. Toxicol.4: 39–46.
18.
FukushimaSKuwabaraNTatematsuMHiroseM (1985). Tumor of the liver. In: Atlas of Tumor Histopathology, NishizukaYTakayamaSItoNHayashiY (eds). Bunkodo, Tokyo, pp. 48–54.
19.
GoldfarbS (1984). Biologic mechanisms of hepatocarcinogenesis. Semin. Liver Dis.4: 89–97.
20.
GoldsworthyTLCampbellHAPitotHC (1984). The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis5: 67–71.
21.
GoldsworthyTLPitotHC (1985). The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital. Carcinogenesis6: 1261–1269.
22.
GoldsworthyTLHaniganMHPitotHC (1986). Models of hepatocarcinogenesis in the rat-Contrasts and comparisons. CRC Crit. Rev. Toxicol.17: 61–89.
23.
GoodmanDGWardJMSquireRAChuKCLinhartMS (1979). Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol. Appl. Pharmacol.48: 237–248.
24.
HackerHJMooreMAMayerDBannaschP (1982). Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis3: 1265–1272.
25.
HaniganMHPitotHC (1985). Gamma-glutamyl transpeptidase-Its role in hepatocarcinogenesis. Carcinogenesis6: 165–172.
26.
HasegawaRKannoJ (1986). Neoplastic lesions of the liver of the rat. J. Toxicol. Sci.11: 462–469.
27.
HasemanJK (1983). Patterns of tumor incidence in two-year cancer bioassay feeding studies in Fischer 344 rats. Fundam. Appl. Toxicol.3: 1–9.
28.
HasemanJKHuffJBoormanGA (1984). Use of historical control data in carcinogenicity studies in rodents. Toxicol. Pathol.12: 126–135.
29.
HayashiY (1985). Histologic typing of liver tumors in rats, mice and hamsters-A workshop report. Exp. Pathol.28: 140–141.
30.
HerrenSLPereiraMABrittALKhouryMK (1982). Initiation/promotion assay for chemical carcinogenesis in rat liver. Toxicol. Lett.12: 143–150.
31.
HirotaNWilliamsGM (1979). The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis. Am. J. Pathol.95: 317–328.
32.
HollanderMWolfeDA (1973). Nonparametric Statistical Methods. John Wiley #38;#38; Sons, New York.
33.
Institute of Laboratory Animal Resources (1980). Histologic typing of liver tumors of the rat. J. Natl. Cancer Inst.64: 178–206.
34.
KarasakiS (1976). Ultrastructural and cytochemical studies on hyperbasophilic foci with special reference to the demonstration of cell surface alterations in hepatocarcinogenesis. Cancer Res.36: 2567–2572.
35.
KoenHPughTDGoldfarbS (1983). Centrilobular distribution of diethylnitrosamine-induced hepatocellular foci in the mouse. Lab. Invest.49: 78–81.
36.
MaronpotRRMontgomeryCAJr.BoormanGAMcConnellEE (1986). National Toxicology Program Nomenclature for hepatoproliferative lesions of rats. Toxicol. Pathol.14: 263–273.
37.
MitakaTTsukadaH (1987). Sexual differences in the histochemical characteristics of “altered cell foci” in the liver of aged Fischer 344 rats. Jpn. J. Cancer Res. (Gann)78: 785–790.
38.
MooreMAMayerDBannaschP (1982). The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis3: 1429–1436.
39.
MooreMAHackerHJKunzHWBannaschP (1983). Enhancement of NNM-induced carcinogenesis in the rat liver by phenobarbital: A combined morphological and enzyme histochemical approach. Carcinogenesis4: 473–479.
40.
NewbernePMMcConnellRG (1980). Toxicologic Pathology: Issues and uncertainties. In: The Principles and Methods in Modern Toxicology, GalliCLMurphySDPaolettiR (eds). Elsevier/North-Holland Biomedical Press, Amsterdam, New York, Oxford, pp. 223–258.
41.
NewbernePM (1982). Assessment of the hepatocarcinogenic potential of chemicals: Response of the liver. In: Toxicology of the Liver, PlaaGHewittWR (eds). Raven Press, New York, pp. 243–290.
42.
OgawaKOnoeTTakeuchiM (1981). Spontaneous occurrence of γ-glutamyl transpeptidase-positive hepatocytic foci in 105-week-old Wistar and 72-week-old Fischer 344 male rats. J. Natl. Cancer Inst.67: 407–412.
43.
OhmoriTKondoMTabeiR (1983). High susceptibility of specific inbred colonies of rats to N-2-fluorenylacetamide-induced hepatocarcinogenesis. Gann74: 822–828.
44.
PerainoCStaffeldtEFCarnesBALudemanVABlomquistJAVesselinovitchSD (1984). Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or bnzo(a) pyrene within one day after birth. Cancer Res.44: 3340–3347.
45.
PereiraMA (1982). Rat liver foci bioassay. J. Am. Coll. Toxicol.1: 101–117.
46.
PitotHC (1979). Biological and enzymatic events in chemical carcinogenesis. Ann. Rev. Med.30: 25–39.
47.
PitotHCSiricaAE (1980). The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta605: 191–215.
48.
PitotHCGlauertHPHaniganM (1985). The significance of selected biochemical markers in the characterization of putative initiated cell populations in rodent liver. Cancer Lett.29: 1–14.
49.
PoppJAScortichiniBHGarveyLK (1985). Quantitative evaluation of hepatic foci of cellular alteration occurring spontaneously in Fischer-344 rats. Fundam. Appl. Toxicol.5: 314–319.
50.
PretlowTPGraneRWGoehringPLLapinskyASPretlowTG (1987). Examination of enzyme-altered foci with gamma-glutamyl transpeptidase, aldehyde dehydrogenase, glucose-6-phosphate dehydrogenase, and other markers in methacrylate-embedded liver. Lab. Invest.56: 96–100.
51.
PughTDKingJHKoenHNychkaDChoverJWahbaGHeYGoldfarbS (1983). Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cancer Res.43: 1261–1268.
52.
RabesHMBucherTHartmannALinkeIDunnwaldM (1982). Clonal growth of carcinogen-induced enzyme-deficient preneoplastic cell populations in mouse liver. Cancer Res.42: 3220–3227.
53.
ReuberMD (1975). Histogenesis of hyperplasia and carcinomas of the liver arising around central veins in mice ingesting chlorinated hydrocarbons. Pathol. Microbiol.43: 287–298.
54.
SatohKKitaharaASomaYInabaYHatayamaISatoK (1985). Purification, induction, and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA82: 3964–3968.
55.
SchererEFriedrich-FreksaH (1970). Zur zentralvene gerichtete wanderung von leberzellen der ratte nach partieller hepatektomic und nach verabfolgung von diathylnitrosamin. Z. Naturforsch.25: 637–642.
56.
SchererEEmmelotP (1976). Kinetics of induction and growth of enzyme-deficient islands involved in hepatocarcinogenesis. Cancer Res.36: 2544–2554.
57.
Schulte-HermannRTimmermann-TrosienerISchupplerJ (1983). Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res.43: 839–844.
58.
SoltDBMedlineAFarberE (1977). Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am. J. Pathol.88: 595–618.
59.
SquireRALevittMH (1975). Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res.35: 3214–3223.
60.
StitzelKA (1986). Spontaneous basophilic foci in F344 females rats do not exclude iron. The 37th Annual Meeting of American College of Veterinary Pathologists.
61.
TatematsuMTsudaHShiraiTMasuiTItoN (1987). Placental glutathione S-transferase (GST-P) as a new marker for hepatocarcinogenesis: In vivo short-term screening for hepatocarcinogens. Toxicol. Pathol.15: 60–72.
62.
TsudaHMooreMAAsamotoMInoueTItoNSatohKIchiharaANakamuraTAmelizadZOeschF (1988). Effect of modifying agents on the phenotypic expression of cytochrome P-450, glutathione S-transferase molecular forms, microsomal epoxide hydrolase, glucose-6-phosphate dehydrogenase and γ-glutamyltranspeptidase in rat liver preneoplastic lesions. Carcinogenesis9: 547–554.
63.
U.S. Environmental Protection Agency (1986). Proliferative hepatocellular lesions of the rat: Review and future use in risk assessment. Risk Assessment Forum.
64.
WardJM (1981). Morphology of foci of altered hepatocytes and naturally-occurring hepatocellular tumors in F344 rats. Virchows Arch.390: 339–345.
65.
WardJM (1983). Increased susceptibility of livers of aged F344/NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms. J. Natl. Cancer Inst.71: 815–823.
66.
WardJMOhshimaM (1985). Evidence for lack of promotion of the growth of the common naturally occurring basophilic focal hepatocellular proliferative lesions in aged F344/NCr rats by phenobarbital. Carcinogenesis6: 1255–1259.
67.
WatanabeKWilliamsGM (1978). Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: Evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. J. Natl. Cancer Inst.61: 1311–1314.
68.
WeberEMooreMABannaschP (1988). Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine. Carcinogenesis9: 1049–1054.
69.
WilliamsGMKlaiberMParkerSEFarberE (1976). Nature of early appearing carcinogen-induced liver lesions resistant to iron accumulation. J. Natl. Cancer Inst.57: 157–165.
70.
WilliamsGMWatanabeK (1978). Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion of persistence following removal of carcinogen. J. Natl. Cancer Inst.61: 113–121.
71.
WilliamsGM (1980). The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochim. Biophys. Acta605: 167–189.
72.
WilliamsGM (1987). The significance of preneoplastic liver lesions in experimental animals. Adv. Vet. Sci. Comp. Med.31: 21–44.
73.
ZerbanHPreussmannRBannaschP (1988). Dose-time relationship of the development of preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine. Carcinogenesis9: 607–610.
